The envelope proteins of dengue and Zika viruses share 54%–59% sequence identity, raising the potential for cross-reactivity between dengue and Zika vaccine antibodies, which could exacerbate dengue symptoms in subsequent infections. The gene discussed is ERVW-1; the disease is dengue disease.